Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-040015)

Filing Details

Accession Number:: 0001209191-14-040015
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-09 20:14:58
Reporting Period:: 2014-06-05

Filing Date:: 2014-06-09
Accepted Time:: 2014-06-09 20:14:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087432	Intermune Inc	ITMN	Pharmaceutical Preparations (2834)	943296648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1469029	A Jonathan Leff	3280 Bayshore Blvd Brisbane CA 94005	Evp, Research & Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-06-05	190	$39.66	46,131	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares sold in this transaction were acquired pursuant to a restricted stock award grant and were sold pursuant to a pre-existing order to sell that number of shares necessary to cover the taxes owed upon the vesting of such restricted stock award.